Intact amphetamine-induced behavioral sensitization in mice with increased or decreased neuronal glutamate transporter SLC1A1/EAAT3

Neurochem Int. 2022 Nov:160:105418. doi: 10.1016/j.neuint.2022.105418. Epub 2022 Sep 9.

Abstract

Repeated amphetamine treatment results in locomotor sensitization, a phenomenon that may relate to the development of psychosis and addiction. Evidence suggests that interactions between dopaminergic and glutamatergic systems are involved in amphetamine sensitization. We previously demonstrated that the neuronal excitatory amino acid transporter (Slc1a1/EAAT3) produces bidirectional, expression-dependent effects on the response to acute amphetamine. Here, using mice with decreased or increased expression of EAAT3, we found that chronic alterations in EAAT3 expression do not significantly impact amphetamine-induced locomotor sensitization. Compensation by other glutamate transporters cannot be ruled out in this important neuroadaptive phenomenon.

Keywords: Amphetamine; Basal ganglia; Dopamine; EAAT3; Glutamate transporters; Sensitization.

Publication types

  • Research Support, N.I.H., Extramural

MeSH terms

  • Amphetamine* / pharmacology
  • Animals
  • Dopamine
  • Excitatory Amino Acid Transporter 3* / genetics
  • Excitatory Amino Acid Transporter 3* / metabolism
  • Glutamic Acid / metabolism
  • Mice
  • Neurons / metabolism

Substances

  • Excitatory Amino Acid Transporter 3
  • Slc1a1 protein, mouse
  • Glutamic Acid
  • Amphetamine
  • Dopamine